Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biotech Research and Development Will Benefit from Sarbanes-Oxley Changes.


BIO Reiterates Support as Senate Small Business Committee Considers Changes

WASHINGTON -- As Securities and Exchange Commission (SEC) Chairman Christopher Cox and Public Companies Accounting Oversight Board (PCAOB PCAOB Public Company Accounting Oversight Board ) Chairman Mark Olsen Mark Olsen may refer to:
  • Mark V. Olsen (20th century), U.S. screenwriter, co-creator of Big Love on HBO
  • Mark S. Olsen (born 1962), New Zealand portrait artist
Or possibly to:
  • Marc Olsen (born 1986), Danish football (soccer) player
 prepare to testify before the Senate Committee on Small Business & Entrepreneurship today, BIO reiterated its support for changes to the Sarbanes-Oxley Act See SOX.  of 2002 (SOX) that will specifically benefit small biotech companies.

"The biotechnology industry was particularly hard-hit by the complex and burdensome regulations imposed by SOX's Section 404. We have supported changes to its implementation, so our companies can refocus on our most important mission of researching and developing new therapies to improve human health, expand our food supply, and provide new sources of energy," said BIO President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  Jim Greenwood. "We are pleased to see that agency and congressional leaders are listening."

The SEC in December released a proposal to provide guidance to management to improve Section 404 by eliminating waste and duplication in SOX compliance procedures. The commission is expected to vote on the new standards by the end of May or early June, in time for the 2007 financial statement audits.

"Our industry looks forward to continuing to work with regulators and policy-makers to establish a more equitable implementation of SOX -- one that maintains the original intent of the law by providing investors with confidence in the financial integrity of public companies while also lessening the burden on small companies like ours who are investing in innovations that are improving life for millions of people," continued Greenwood.

About BIO

BIO represents more than 1,100 biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
, academic institutions, state biotechnology centers and related organizations across the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology Environmental biotechnology is when biotechnology is applied to and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation.  products. BIO also produces the annual BIO International Convention, the global event for biotechnology.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 18, 2007
Words:308
Previous Article:Media Alert/Right Media Executives to Speak at ad:tech San Francisco.
Next Article:FASB Issues an Exposure Draft to Improve the Accounting for Financial Guarantee Insurance Contracts.
Topics:



Related Articles
Legislation, regulation, and the role of the AMC: as illustrated with the Sarbanes-Oxley Act, AMCs play a key role in informing and protecting their...
PCAOB issues internal control standards ED.
Ask FERF (financial executives research foundation) about ... private company compliance with section 404.
Tips for the Sarbanes-Oxley learning curve: the act has brought more complexity to firm management; here's some broad-based help.
Is software the solution for Sarbanes-Oxyley.
Under the gun: Sarbanes-Oxley compliance requires significantly more investment than public insurers anticipated. Now mutuals may have to comply as...
The value proposition: there's more to Sarbanes-Oxley compliance than meets the eye.
Sarbanes-Oxley report card is mixed: three years after the law was enacted, has it made a demonstrable difference in the level of corporate fraud?...
Cherry-picking Sarbanes-Oxley: provisions that deserve a second look.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles